Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
PEARL
Pain, Emotional Allodynia, and Relational Load (PEARL): A Multicenter Validation Study of the Emotional Allodynia Questionnaire in Fibromyalgia
2 other identifiers
observational
423
1 country
5
Brief Summary
The Emotional Allodynia Questionnaire (AEQ) is an 11-item self-report instrument that measures disproportionate emotional reactivity to low-intensity interpersonal cues(perceived unresponsiveness, exclusion, loss of reciprocity), a pattern termed emotional allodynia. It was preliminarily validated in a single-center fibromyalgia sample. PEARL (validation phase) is a multicenter, prospective, observational psychometric validation study that (1) replicates the internal structure and convergent validity of the AEQ in an independent fibromyalgia sample, (2) tests its known-groups (discriminative) accuracy in separating fibromyalgia from non-fibromyalgia chronic pain of defined nociceptive or neuropathic origin, expressed as the area under the ROC curve (AUC), and (3) assesses test-retest reliability. There is no intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2025
CompletedFirst Submitted
Initial submission to the registry
June 20, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
July 1, 2026
June 1, 2026
1.7 years
June 20, 2026
June 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Internal consistency of the Emotional Allodynia Questionnaire (AEQ) in fibromyalgia cases
Internal consistency reliability of the AEQ, an 11-item self-report questionnaire (total score range 0-44), in fibromyalgia cases, assessed using Cronbach's alpha and McDonald's omega, each reported with 95% confidence intervals.
Baseline (T0)
Factorial structure of the Emotional Allodynia Questionnaire (AEQ)
Latent factor structure of the 11-item AEQ self-report questionnaire, assessed by exploratory factor analysis and a single-factor confirmatory factor analysis (CFA). Reported as CFA model fit indices: comparative fit index (CFI), Tucker-Lewis index (TLI), root mean square error of approximation (RMSEA), and standardized root mean square residual (SRMR).
Baseline (T0)
Known-groups discriminative accuracy of the AEQ (AUC)
Discriminative accuracy of the AEQ total score (11-item self-report questionnaire) in distinguishing fibromyalgia cases from non-fibromyalgia chronic pain controls, reported as the area under the receiver operating characteristic (ROC) curve (AUC, range 0-1) with 95% confidence interval, tested against a null value of 0.70.
Baseline (T0)
Secondary Outcomes (6)
Convergent validity of the Emotional Allodynia Questionnaire (AEQ)
Baseline (T0)
Discriminant validity of the Emotional Allodynia Questionnaire (AEQ) versus the DERS
Baseline (T0)
Test-retest reliability of the Emotional Allodynia Questionnaire (AEQ) total score
Baseline (T0) and retest at approximately 40 days (plus or minus 10 days)
AEQ score distribution across AEQ-CSI median-split phenotypes
Baseline (T0)
Floor and ceiling effects of the Emotional Allodynia Questionnaire (AEQ)
Baseline (T0)
- +1 more secondary outcomes
Other Outcomes (1)
Concordance between AEQ-CSI phenotypes and data-driven clusters
Baseline (T0)
Study Arms (2)
Fibromyalgia cases
Adults with fibromyalgia diagnosed per the 2016 ACR criteria.
Non-fibromyalgia chronic pain controls
Adults with chronic non-cancer pain of defined nociceptive or neuropathic origin who do not meet the 2016 ACR criteria for fibromyalgia.
Eligibility Criteria
Adults attending Italian tertiary pain outpatient services. Cases are identified from fibromyalgia services; controls are identified among patients attending the same services for chronic non-cancer pain of defined nociceptive or neuropathic origin. Consecutive eligible patients are considered for enrollment.
You may qualify if:
- Age 18 years or older
- Clinical diagnosis of fibromyalgia confirmed according to the 2016 revision of the ACR criteria
- Chronic non-cancer pain for at least 3 months
- Ability to understand and independently complete self-report questionnaires in Italian
- Willingness to provide written informed consent
You may not qualify if:
- Active oncological disease or cancer-related pain
- Any current or past psychiatric diagnosis except Major Depressive Disorder and Panic Disorder (assessed by clinical history)
- Severe cognitive impairment precluding questionnaire completion
- Inability to understand or complete questionnaires in Italian
- CONTROLS (non-fibromyalgia chronic pain)
- Age 18 years or older
- Chronic non-cancer pain for at least 3 months with a defined nociceptive or neuropathic generator (e.g., radiologically or surgically documented degenerative, structural, or post-surgical musculoskeletal pain, or neuropathic pain with an identifiable neurological lesion or disease)
- Not meeting the 2016 ACR criteria for fibromyalgia
- Ability to understand and independently complete self-report questionnaires in Italian
- Willingness to provide written informed consent
- Diagnosis of fibromyalgia or another recognized nociplastic primary pain condition (e.g., primary chronic widespread pain)
- Active oncological disease or cancer-related pain
- Any current or past psychiatric diagnosis except Major Depressive Disorder and Panic Disorder
- Severe cognitive impairment precluding questionnaire completion
- Inability to understand or complete questionnaires in Italian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Barilead
- Universita di Veronacollaborator
- University of Campania Luigi Vanvitellicollaborator
- University of Cagliaricollaborator
- IRCCS Azienda Ospedaliero-Universitaria di Bolognacollaborator
Study Sites (5)
Pain Unit, Policlinico di Bari, University of Bari Aldo Moro (coordinating center)
Bari, 70124, Italy
Anesthesia and Pain Therapy Unit, IRCCS AOSP di Bologna, Policlinico S. Orsola-Malpighi
Bologna, 40138, Italy
Department of Medical Sciences and Public Health, University of Cagliari
Cagliari, Italy
Department of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli
Naples, Italy
Department of Surgery, Dentistry, Pediatrics and Gynecology, University of Verona
Verona, Italy
Related Publications (1)
Corriero A, Giglio M, Pilolla A, Galdini F, Mucci O, Vurro M, Fornarelli F, Di Venosa C, Trerotoli P, Puntillo F. The Emotional Allodynia Questionnaire: Preliminary Validation and Clinical Phenotyping in Fibromyalgia. J Pain Res. 2026 Jun 3;19:607309. doi: 10.2147/JPR.S607309. eCollection 2026.
PMID: 42261300BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alberto Corriero, MD, PhD
University of Bari Aldo Moro, Pain and ICU Section
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 20, 2026
First Posted
July 1, 2026
Study Start
September 10, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
July 1, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared publicly. Under Italian data protection regulations and the EU General Data Protection Regulation (GDPR), participant-level data from this study cannot be made publicly available. The working dataset is pseudonymized and held on secure institutional systems. De-identified data supporting the main findings may be made available from the corresponding author upon reasonable request, subject to a data-sharing agreement and compliance with applicable data-protection requirements.